BioCryst Pharmaceuticals Has Returned 21.6% Since SmarTrend Recommendation (BCRX)
May 16, 2017 at 02:29 AM EDT
SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on April 6th, 2017 at $7.46. In approximately 1 month, BioCryst Pharmaceuticals has returned 21.60% as of today's recent price of...
